A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 28,696 shares of BIO stock, worth $10.7 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
28,696
Previous 33,386 14.05%
Holding current value
$10.7 Million
Previous $11.5 Million 32.13%
% of portfolio
0.1%
Previous 0.18%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $1.26 Million - $1.59 Million
-4,690 Reduced 14.05%
28,696 $7.84 Million
Q1 2024

May 15, 2024

SELL
$304.11 - $351.99 $1.22 Million - $1.42 Million
-4,028 Reduced 10.77%
33,386 $11.5 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $3.97 Million - $5.38 Million
14,743 Added 65.03%
37,414 $12.1 Million
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $6.27 Million - $7.56 Million
17,891 Added 374.29%
22,671 $8.13 Million
Q2 2023

Aug 14, 2023

BUY
$359.49 - $486.4 $703,521 - $951,884
1,957 Added 69.32%
4,780 $1.81 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $321,553 - $386,304
768 Added 37.37%
2,823 $1.35 Million
Q4 2022

Feb 14, 2023

BUY
$351.71 - $456.01 $50,646 - $65,665
144 Added 7.54%
2,055 $864,000
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $604,444 - $825,175
-1,465 Reduced 43.39%
1,911 $797,000
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $1.5 Million - $1.93 Million
-3,236 Reduced 48.94%
3,376 $1.67 Million
Q1 2022

May 16, 2022

SELL
$524.57 - $735.42 $542,929 - $761,159
-1,035 Reduced 13.53%
6,612 $3.72 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $4.34 Million - $4.87 Million
6,125 Added 402.43%
7,647 $5.78 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $834,633 - $1.05 Million
-1,269 Reduced 45.47%
1,522 $1.14 Million
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $1.86 Million - $2.1 Million
-3,233 Reduced 53.67%
2,791 $1.8 Million
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $2.39 Million - $2.9 Million
4,376 Added 265.53%
6,024 $3.44 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $316,621 - $398,939
-620 Reduced 27.34%
1,648 $961,000
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $5.73 Million - $6.76 Million
-12,613 Reduced 84.76%
2,268 $1.17 Million
Q2 2020

Aug 13, 2020

SELL
$334.87 - $493.06 $1.07 Million - $1.57 Million
-3,189 Reduced 17.65%
14,881 $6.72 Million
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $623,059 - $796,459
-1,947 Reduced 9.73%
18,070 $6.34 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $478,955 - $560,551
1,498 Added 8.09%
20,017 $7.41 Million
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $3.48 Million - $3.94 Million
11,411 Added 160.54%
18,519 $6.16 Million
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $1.36 Million - $1.48 Million
4,731 Added 199.03%
7,108 $2.22 Million
Q1 2019

May 15, 2019

SELL
$224.3 - $317.41 $1.13 Million - $1.6 Million
-5,026 Reduced 67.89%
2,377 $727,000
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $88,260 - $123,909
401 Added 5.73%
7,403 $1.72 Million
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $2.03 Million - $2.28 Million
7,002 New
7,002 $2.19 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $9.19B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.